Search filters

List of works by Scott D Berkowitz

Acute profound thrombocytopenia after C7E3 Fab (abciximab) therapy.

scientific article

Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty

scientific article published on 01 February 2014

Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy

scientific article published on 4 February 2013

Antithrombotic therapy after prosthetic cardiac valve implantation: improving postoperative, long-term patient management. Introduction

scientific article published on 01 May 2001

Antithrombotic therapy after prosthetic cardiac valve implantation: potential novel antithrombotic therapies.

scientific article

Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.

scientific article

Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolism

scientific article published on 23 April 2020

Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the treatment of venous thromboembolism

scientific article published on 23 April 2020

Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty

scientific article published on 26 March 2014

Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.

scientific article

Bleeding complications with platelet glycoprotein IIb/IIIa receptor antagonists.

scientific article

Blood pressure control and stroke or bleeding risk in anticoagulated patients with atrial fibrillation: Results from the ROCKET AF Trial

scientific article published on 6 May 2016

Cardiovascular drug development: is it dead or just hibernating?

scientific article published on April 2015

Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

scientific article

Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial.

scientific article published on 7 March 2018

Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial

scientific article

Coagulation complicating cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia receiving the heparinoid, danaparoid sodium.

scientific article published in December 1997

Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers

scientific article published on 24 July 2014

Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement.

scientific article

Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study.

scientific article published in October 2003

Complication rates after hip or knee arthroplasty in morbidly obese patients

scientific article published on 14 May 2013

Current knowledge of the platelet glycoprotein IIb/IIIa receptor antagonists for the treatment of coronary artery disease.

scientific article

Determination of platelet aggregation inhibition during percutaneous coronary intervention with the platelet function analyzer PFA-100

scientific article (publication date: July 2002)

Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Tr

scientific article

Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial).

scientific article

Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: a double-blind, dose-ranging study. Ardeparin Arthroplasty Study Group.

scientific article

Efficacy and safety of rivaroxaban compared with warfarin in patients with carotid artery disease and nonvalvular atrial fibrillation: Insights from the ROCKET AF trial.

scientific article published in February 2018

Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: The Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial F

article by Sameer Bansilal et al published October 2015 in American Heart Journal

Efficacy and safety of rivaroxaban in patients with heart failure and nonvalvular atrial fibrillation: insights from ROCKET AF.

scientific article published on 30 May 2013

Efficacy and safety of rivaroxaban versus warfarin in patients from mainland China with nonvalvular atrial fibrillation: A subgroup analysis from the ROCKET AF trial

scientific article published on 13 April 2017

Efficacy of abciximab readministration in coronary intervention.

scientific article

Embolic strokes of undetermined source: Prevalence and patient features in the ESUS Global Registry

scientific article published on 11 April 2016

End of study transition from study drug to open-label vitamin K antagonist therapy: the ROCKET AF experience

scientific article

Evaluation of drug-induced serious hepatotoxicity (eDISH): application of this data organization approach to phase III clinical trials of rivaroxaban after total hip or knee replacement surgery

scientific article

Evidence that calpains and elastase do not produce the von Willebrand factor fragments present in normal plasma and IIA von Willebrand disease

scientific article published on 01 August 1988

Evidence-Based Development and Rationale for Once-Daily Rivaroxaban Dosing Regimens Across Multiple Indications.

scientific article published on 18 February 2016

Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation).

scientific article

Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial.

scientific article

Glycoprotein IIb/IIIa integrin blockade

scientific article published on 01 December 1998

Graft-versus-leukemia in the rat--the antileukemic efficacy of syngeneic and allogeneic graft-versus-host disease

scientific article published on 01 February 1987

Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial

scientific article

Hospitalizations in patients with atrial fibrillation: an analysis from ROCKET AF

scientific article published on 12 May 2016

Influence of model-predicted rivaroxaban exposure and patient characteristics on efficacy and safety outcomes in patients with acute coronary syndrome

scientific article published on 01 January 2019

Intracranial Hemorrhage Among Patients With Atrial Fibrillation Anticoagulated With Warfarin or Rivaroxaban

article

Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges ⬇️

scientific article published on 06 January 2013

Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial

scientific article

Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban

scientific article published on 17 February 2016

Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF.

scientific article published in April 2018

New heparin dosing recommendations for patients with acute coronary syndromes

scientific article (publication date: June 2001)

Novel oral anticoagulants and reversal agents: Considerations for clinical development

scientific article published on 26 March 2015

On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF.

scientific article published on July 2016

Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty.

scientific article

Oral heparin administration with a novel drug delivery agent (SNAC) in healthy volunteers and patients undergoing elective total hip arthroplasty

scientific article published on 01 September 2003

Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials.

scientific article published on 28 September 2014

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies

scientific article published on 20 September 2013

Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Preven

scientific article published on February 2013

Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation

scientific article published on 16 December 2015

Preclinical differentiation of low molecular weight heparins.

scientific article

Progress in point-of-care laboratory testing for assessing platelet function

scientific article published on 01 October 1998

Prospective comparison of hemorrhagic complications after treatment with enoxaparin versus unfractionated heparin for unstable angina pectoris or non–ST-segment elevation acute myocardial infarction ⬇️

scientific article (publication date: December 2001)

Proteolysis of von Willebrand factor after thrombolytic therapy in patients with acute myocardial infarction ⬇️

scientific article published on January 1, 1992

Proteolytic degradation of von Willebrand factor after DDAVP administration in normal individuals

scientific article published on 01 July 1987

Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial

scientific article published on 30 July 2018

Relation between inhibition of platelet aggregation and clinical outcomes

scientific article published on 01 October 1998

Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention o

Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results from the ROCKET AF trial

scientific article

Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".

scientific article published in July 2016

Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial

scientific article published in February 2021

Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source

article published in 2018

Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial

article

Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial

scientific article published on 24 April 2014

Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies.

scientific article published on 6 December 2010

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

scientific article published on 18 March 2017

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

scientific article published in September 2018

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial

scientific article

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

scientific article published on 10 November 2017

Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis-mediated conditions.

scientific article published on 23 May 2013

Safety and Efficacy of Rivaroxaban in Patients With Cardiac Implantable Electronic Devices: Observations From the ROCKET AF Trial

scientific article published on 14 June 2017

Sialic acid prevents loss of large von Willebrand factor multimers by protecting against amino-terminal proteolytic cleavage

scientific article published on 01 November 1988

Subunit composition of plasma von Willebrand factor in patients with the myeloproliferative syndrome

scientific article published on 01 December 1986

The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results

scientific article published on November 1, 2003

The determinants of activated partial thromboplastin time, relation of activated partial thromboplastin time to clinical outcomes, and optimal dosing regimens for heparin treated patients with acute coronary syndromes: a review of GUSTO-IIb

scientific article

The discovery and development of rivaroxaban.

scientific article published on March 2011

The discovery of rivaroxaban: translating preclinical assessments into clinical practice.

scientific article

The effects of rivaroxaban on the complications of surgery after total hip or knee replacement: results from the RECORD programme.

scientific article published in November 2012

Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atr

scientific article

Treatment of established deep vein thrombosis: a review of the therapeutic armamentarium

scientific article published on 01 July 1995

Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial

scientific article

Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention: The ROCKET AF Trial.

scientific article

Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial

scientific article published on 22 June 2016

Paulina is supported by:

About Paulina

Help